Dr. Oliver Freudenreich is the medical director of the Massachusetts General Hospital Schizophrenia Program. He also directs the Infectious Disease Psychiatry Consultation Service in the Division of Psychiatry and Medicine at MGH. He is an associate professor of psychiatry at Harvard Medical School.
Dr. Freudenreich received his medical degree from the University of Heidelberg in Germany. He completed his psychiatric residency at UMDNJ/Rutgers in New Jersey. Additional training included a 2-year fellowship at Duke University in psychiatric research and a 1-year fellowship at MGH in psychosomatic medicine. The Duke fellowship exposed him to clinical trials methodology as well as sophisticated psychopharmacology of schizophrenia. For his involvement in research and teaching, he has received fellowships from the Society of Biological Psychiatry, from the Academy of Psychosomatic Medicine, and the American Association of Directors of Psychiatric Residency Training.
Dr. Freudenreich works as an attending psychiatrist and resident supervisor in the MGH Schizophrenia Program at the Freedom Trail Clinic in the Erich Lindemann Mental Health Center. His academic interest is in the area of optimal psychopharmacological treatment for schizophrenia, including clozapine for refractory psychosis, early course schizophrenia, the role of medical morbidity in schizophrenia, and treatment adherence. In addition to his expertise in schizophrenia, Dr. Freudenreich provides psychiatric consultations and collaborative care for medically complex patients of the MGH Infectious Disease Clinic, many of which are diagnosed with HIV/AIDS.